I believe in combining the latest advances in cancer treatment with an individualized approach to each person in order to change a patient’s outcome from this disease. We know that no brain cancer is routine and I work to develop specific treatment plans for each patient and each tumor, providing the right treatment at the right time. I also provide such care for my patients in a comprehensive, compassionate manner because I believe that preserving a person’s dignity and quality of life is as important as increasing their life span
I found my calling in combining the best of patient care and cutting- edge research in order to build the next generation of treatments for this disease. Along with the team of expert clinicians in our Brain and Spine Tumor center, we are working to make definitive and lasting improvement in the lives of our patients.
I find my inspiration in passionately working with our team of accomplished faculty and staff at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute to bring the most advanced treatment for our patients with brain and spine tumors I strongly believe that together we can make a real difference in the lives of our patients.
Bangalore Medical College & Research Institute
University of Texas Health Sciences Center
7/1/1993 - 6/30/1996
Specialties and conditions I treat
- Brain Cancers
- Quality of Life
- Translational Medical Research
- Spinal Cord Tumors
Locations where I practice
More about my work
National Institute of Mental Health and Neuroscience
12/1/1990 - 7/30/1991
The University of Texas MD Anderson Cancer Center
7/1/1996 - 6/30/1998
American Board of Psychiatry & Neurology (Subspecialty: Neurology)
News about me
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/25/2016, Dr. Puduvalli has reported financial relationships with the medical device, research and/or drug companies listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office at 614-293-7802.
- Gilead Sciences, Inc.
- Threshold Pharmaceuticals